Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (642295)
Received: 6 March 2019
Accepted: 23 September 2019
First Online: 7 October 2019
Ethics approval and consent to participate
: The data collection in this study was retrospective. It was approved and registered as a retrospective clinical trial (ClinicalTrials gov identifier: NCT02581228), according to the requirements of the Helsinki Committee at HMC (0403-15-HMO), and upon signing a secrecy declaration prior to data retrieval at UMM.
: Not applicable.
: ZA holds 15% shares in Optimata. Other authors declare that they have no competing interests.